DSC
CRL icon

Duncker Streett & Co’s Charles River Laboratories CRL Stock Holding History

Duncker Streett & Co’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-336
Closed -$95K – 483
2022
Q1 		$95K Buy
336
+24
+8% +$7.4K 0.02% 280
2021
Q4 		$118K Buy
+312
New +$121K 0.02% 280

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Duncker Streett & Co's CRL Position: Q2 2022 in Review

Duncker Streett & Co sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 336 shares — an estimated $95K sold.

Duncker Streett & Co first reported a position in CRL in Q4 2021 and held it in 2 quarters. The position peaked at $118K in Q4 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

  • Duncker Streett & Co reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
  • Duncker Streett & Co sold 336 Charles River Laboratories shares in Q2 2022, an estimated $95K.
  • Duncker Streett & Co first reported a position in Charles River Laboratories in Q4 2021 and held it in 2 quarters.
  • Duncker Streett & Co's Charles River Laboratories position peaked at $118K in Q4 2021.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Duncker Streett & Co's 13F filing for Q2 2022, filed 4 Aug 2022.